Literature DB >> 9272362

Methods for estimating serological correlates of protection.

G R Siber1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9272362

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


× No keyword cloud information.
  13 in total

Review 1.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

2.  Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency.

Authors:  F M Cavaliere; C Milito; H Martini; M Schlesier; R Dräger; K Schütz; G Brunetti; A M Pesce; V Thon; K Warnatz; I Quinti
Journal:  J Clin Immunol       Date:  2012-12-29       Impact factor: 8.317

3.  Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children.

Authors:  B Mikoluc; H Kayhty; E Bernatowska; R Motkowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

4.  Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Authors:  Nick Andrews; Ray Borrow; Elizabeth Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

5.  FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

Authors:  Shuying S Li; Peter B Gilbert; Georgia D Tomaras; Gustavo Kijak; Guido Ferrari; Rasmi Thomas; Chul-Woo Pyo; Susan Zolla-Pazner; David Montefiori; Hua-Xin Liao; Gary Nabel; Abraham Pinter; David T Evans; Raphael Gottardo; James Y Dai; Holly Janes; Daryl Morris; Youyi Fong; Paul T Edlefsen; Fusheng Li; Nicole Frahm; Michael D Alpert; Heather Prentice; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Merlin L Robb; Robert J O'Connell; Barton F Haynes; Nelson L Michael; Jerome H Kim; M Juliana McElrath; Daniel E Geraghty
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

6.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.

Authors:  Peter B Gilbert; Li Qin; Steven G Self
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

7.  Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.

Authors:  Anne Benoit; Jiri Beran; Jeanne-Marie Devaster; Meral Esen; Odile Launay; Geert Leroux-Roels; Janet E McElhaney; Lidia Oostvogels; Gerrit A van Essen; Manjusha Gaglani; Lisa A Jackson; Timo Vesikari; Catherine Legrand; Fabian Tibaldi; Bruce L Innis; Walthère Dewé
Journal:  Open Forum Infect Dis       Date:  2015-05-14       Impact factor: 3.835

8.  A threshold method for immunological correlates of protection.

Authors:  Xuan Chen; Fabrice Bailleux; Kamal Desai; Li Qin; Andrew J Dunning
Journal:  BMC Med Res Methodol       Date:  2013-03-01       Impact factor: 4.615

9.  Human immunity and the design of multi-component, single target vaccines.

Authors:  Allan Saul; Michael P Fay
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

Review 10.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.